nodes	percent_of_prediction	percent_of_DWPC	metapath
Cladribine—ABCG2—Glyburide—type 2 diabetes mellitus	0.042	0.395	CbGbCtD
Cladribine—SLC22A2—Metformin—type 2 diabetes mellitus	0.0345	0.324	CbGbCtD
Cladribine—SLC22A1—Metformin—type 2 diabetes mellitus	0.03	0.281	CbGbCtD
Cladribine—POLE3—islet of Langerhans—type 2 diabetes mellitus	0.00573	0.0383	CbGeAlD
Cladribine—SLC28A3—islet of Langerhans—type 2 diabetes mellitus	0.00536	0.0359	CbGeAlD
Cladribine—POLE4—liver—type 2 diabetes mellitus	0.00528	0.0353	CbGeAlD
Cladribine—PNP—kidney—type 2 diabetes mellitus	0.00462	0.0309	CbGeAlD
Cladribine—POLE2—liver—type 2 diabetes mellitus	0.00462	0.0309	CbGeAlD
Cladribine—POLE3—nephron tubule—type 2 diabetes mellitus	0.00461	0.0309	CbGeAlD
Cladribine—RRM2B—pancreas—type 2 diabetes mellitus	0.00426	0.0285	CbGeAlD
Cladribine—RRM2B—cortex of kidney—type 2 diabetes mellitus	0.00418	0.0279	CbGeAlD
Cladribine—POLE3—cardiovascular system—type 2 diabetes mellitus	0.00414	0.0277	CbGeAlD
Cladribine—POLE3—kidney—type 2 diabetes mellitus	0.00405	0.0271	CbGeAlD
Cladribine—POLE3—pancreas—type 2 diabetes mellitus	0.00403	0.0269	CbGeAlD
Cladribine—POLE3—cortex of kidney—type 2 diabetes mellitus	0.00395	0.0264	CbGeAlD
Cladribine—NR5A1—pancreas—type 2 diabetes mellitus	0.0039	0.0261	CbGeAlD
Cladribine—RRM2B—adipose tissue—type 2 diabetes mellitus	0.00386	0.0259	CbGeAlD
Cladribine—SLC28A3—pancreas—type 2 diabetes mellitus	0.00377	0.0252	CbGeAlD
Cladribine—POLE3—adipose tissue—type 2 diabetes mellitus	0.00365	0.0244	CbGeAlD
Cladribine—SLC28A3—adipose tissue—type 2 diabetes mellitus	0.00342	0.0229	CbGeAlD
Cladribine—POLA1—retina—type 2 diabetes mellitus	0.00322	0.0215	CbGeAlD
Cladribine—POLE—cortex of kidney—type 2 diabetes mellitus	0.00301	0.0201	CbGeAlD
Cladribine—RRM1—islet of Langerhans—type 2 diabetes mellitus	0.00299	0.02	CbGeAlD
Cladribine—PNP—liver—type 2 diabetes mellitus	0.00292	0.0195	CbGeAlD
Cladribine—POLE—adipose tissue—type 2 diabetes mellitus	0.00279	0.0186	CbGeAlD
Cladribine—RRM2B—liver—type 2 diabetes mellitus	0.00271	0.0181	CbGeAlD
Cladribine—RRM2—cardiovascular system—type 2 diabetes mellitus	0.0026	0.0174	CbGeAlD
Cladribine—POLE3—liver—type 2 diabetes mellitus	0.00256	0.0171	CbGeAlD
Cladribine—RRM1—retina—type 2 diabetes mellitus	0.00256	0.0171	CbGeAlD
Cladribine—RRM2—kidney—type 2 diabetes mellitus	0.00255	0.017	CbGeAlD
Cladribine—RRM1—nephron tubule—type 2 diabetes mellitus	0.00241	0.0161	CbGeAlD
Cladribine—POLA1—adipose tissue—type 2 diabetes mellitus	0.0024	0.0161	CbGeAlD
Cladribine—DCK—islet of Langerhans—type 2 diabetes mellitus	0.00232	0.0155	CbGeAlD
Cladribine—RRM2—adipose tissue—type 2 diabetes mellitus	0.00229	0.0154	CbGeAlD
Cladribine—Azacitidine—DNMT1—type 2 diabetes mellitus	0.00229	0.213	CrCbGaD
Cladribine—SLC22A2—nephron tubule—type 2 diabetes mellitus	0.00226	0.0151	CbGeAlD
Cladribine—Decitabine—DNMT1—type 2 diabetes mellitus	0.00223	0.208	CrCbGaD
Cladribine—RRM1—cardiovascular system—type 2 diabetes mellitus	0.00216	0.0145	CbGeAlD
Cladribine—RRM1—kidney—type 2 diabetes mellitus	0.00212	0.0142	CbGeAlD
Cladribine—RRM1—pancreas—type 2 diabetes mellitus	0.0021	0.0141	CbGeAlD
Cladribine—RRM1—cortex of kidney—type 2 diabetes mellitus	0.00206	0.0138	CbGeAlD
Cladribine—DCK—retina—type 2 diabetes mellitus	0.00199	0.0133	CbGeAlD
Cladribine—SLC22A2—kidney—type 2 diabetes mellitus	0.00198	0.0133	CbGeAlD
Cladribine—POLE—liver—type 2 diabetes mellitus	0.00195	0.0131	CbGeAlD
Cladribine—Adenosine monophosphate—PRKAA1—type 2 diabetes mellitus	0.00195	0.181	CrCbGaD
Cladribine—Vidarabine—DPP4—type 2 diabetes mellitus	0.00193	0.18	CrCbGaD
Cladribine—SLC22A2—cortex of kidney—type 2 diabetes mellitus	0.00193	0.0129	CbGeAlD
Cladribine—RRM1—adipose tissue—type 2 diabetes mellitus	0.00191	0.0128	CbGeAlD
Cladribine—DCK—nephron tubule—type 2 diabetes mellitus	0.00187	0.0125	CbGeAlD
Cladribine—POLA1—liver—type 2 diabetes mellitus	0.00168	0.0113	CbGeAlD
Cladribine—DCK—pancreas—type 2 diabetes mellitus	0.00163	0.0109	CbGeAlD
Cladribine—RRM2—liver—type 2 diabetes mellitus	0.00161	0.0108	CbGeAlD
Cladribine—DCK—cortex of kidney—type 2 diabetes mellitus	0.0016	0.0107	CbGeAlD
Cladribine—Adenosine—DPP4—type 2 diabetes mellitus	0.00155	0.144	CrCbGaD
Cladribine—DCK—adipose tissue—type 2 diabetes mellitus	0.00148	0.00991	CbGeAlD
Cladribine—SLC22A1—kidney—type 2 diabetes mellitus	0.0014	0.00938	CbGeAlD
Cladribine—RRM1—liver—type 2 diabetes mellitus	0.00134	0.00895	CbGeAlD
Cladribine—SLC22A1—adipose tissue—type 2 diabetes mellitus	0.00126	0.00845	CbGeAlD
Cladribine—ABCG2—nephron tubule—type 2 diabetes mellitus	0.00104	0.00698	CbGeAlD
Cladribine—DCK—liver—type 2 diabetes mellitus	0.00104	0.00695	CbGeAlD
Cladribine—SLC22A1—liver—type 2 diabetes mellitus	0.000886	0.00593	CbGeAlD
Cladribine—ABCG2—adipose tissue—type 2 diabetes mellitus	0.000826	0.00553	CbGeAlD
Cladribine—Adenosine monophosphate—SRC—type 2 diabetes mellitus	0.000786	0.0733	CrCbGaD
Cladribine—ABCG2—liver—type 2 diabetes mellitus	0.000579	0.00388	CbGeAlD
Cladribine—Nausea—Glipizide—type 2 diabetes mellitus	0.000271	0.000582	CcSEcCtD
Cladribine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00027	0.000581	CcSEcCtD
Cladribine—Hypotension—Valsartan—type 2 diabetes mellitus	0.00027	0.000581	CcSEcCtD
Cladribine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00027	0.00058	CcSEcCtD
Cladribine—Pain—Gliclazide—type 2 diabetes mellitus	0.000269	0.000579	CcSEcCtD
Cladribine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000269	0.000579	CcSEcCtD
Cladribine—Rash—Glimepiride—type 2 diabetes mellitus	0.000268	0.000577	CcSEcCtD
Cladribine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000268	0.000576	CcSEcCtD
Cladribine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000267	0.000575	CcSEcCtD
Cladribine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000267	0.000574	CcSEcCtD
Cladribine—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000267	0.000574	CcSEcCtD
Cladribine—Headache—Glimepiride—type 2 diabetes mellitus	0.000266	0.000573	CcSEcCtD
Cladribine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000266	0.000572	CcSEcCtD
Cladribine—Cough—Irbesartan—type 2 diabetes mellitus	0.000266	0.000572	CcSEcCtD
Cladribine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000266	0.000571	CcSEcCtD
Cladribine—Anaemia—Losartan—type 2 diabetes mellitus	0.000265	0.00057	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000264	0.000567	CcSEcCtD
Cladribine—Oedema—Metformin—type 2 diabetes mellitus	0.000264	0.000567	CcSEcCtD
Cladribine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000263	0.000565	CcSEcCtD
Cladribine—Infection—Metformin—type 2 diabetes mellitus	0.000262	0.000563	CcSEcCtD
Cladribine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000262	0.000563	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000261	0.00056	CcSEcCtD
Cladribine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.00026	0.000559	CcSEcCtD
Cladribine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00026	0.000558	CcSEcCtD
Cladribine—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000259	0.000558	CcSEcCtD
Cladribine—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000259	0.000558	CcSEcCtD
Cladribine—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000259	0.000558	CcSEcCtD
Cladribine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000259	0.000556	CcSEcCtD
Cladribine—Malaise—Losartan—type 2 diabetes mellitus	0.000259	0.000556	CcSEcCtD
Cladribine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000259	0.000556	CcSEcCtD
Cladribine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000258	0.000556	CcSEcCtD
Cladribine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000258	0.000556	CcSEcCtD
Cladribine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000258	0.000555	CcSEcCtD
Cladribine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000258	0.000555	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000258	0.000554	CcSEcCtD
Cladribine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000258	0.000554	CcSEcCtD
Cladribine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000257	0.000553	CcSEcCtD
Cladribine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000257	0.000552	CcSEcCtD
Cladribine—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000256	0.000551	CcSEcCtD
Cladribine—Skin disorder—Metformin—type 2 diabetes mellitus	0.000256	0.00055	CcSEcCtD
Cladribine—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000255	0.000549	CcSEcCtD
Cladribine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000255	0.000548	CcSEcCtD
Cladribine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000255	0.000547	CcSEcCtD
Cladribine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000254	0.000546	CcSEcCtD
Cladribine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000253	0.000543	CcSEcCtD
Cladribine—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000252	0.000543	CcSEcCtD
Cladribine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000252	0.000542	CcSEcCtD
Cladribine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000252	0.000541	CcSEcCtD
Cladribine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000252	0.000541	CcSEcCtD
Cladribine—Anorexia—Metformin—type 2 diabetes mellitus	0.000251	0.00054	CcSEcCtD
Cladribine—Cough—Losartan—type 2 diabetes mellitus	0.00025	0.000538	CcSEcCtD
Cladribine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00025	0.000538	CcSEcCtD
Cladribine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.00025	0.000537	CcSEcCtD
Cladribine—Alopecia—Ramipril—type 2 diabetes mellitus	0.00025	0.000537	CcSEcCtD
Cladribine—Fatigue—Valsartan—type 2 diabetes mellitus	0.00025	0.000536	CcSEcCtD
Cladribine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000249	0.000535	CcSEcCtD
Cladribine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000249	0.000535	CcSEcCtD
Cladribine—Oedema—Irbesartan—type 2 diabetes mellitus	0.000249	0.000535	CcSEcCtD
Cladribine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000249	0.000534	CcSEcCtD
Cladribine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000248	0.000534	CcSEcCtD
Cladribine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000248	0.000532	CcSEcCtD
Cladribine—Constipation—Valsartan—type 2 diabetes mellitus	0.000247	0.000532	CcSEcCtD
Cladribine—Infection—Irbesartan—type 2 diabetes mellitus	0.000247	0.000531	CcSEcCtD
Cladribine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000247	0.000531	CcSEcCtD
Cladribine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000247	0.00053	CcSEcCtD
Cladribine—Hypotension—Metformin—type 2 diabetes mellitus	0.000246	0.000529	CcSEcCtD
Cladribine—Erythema—Ramipril—type 2 diabetes mellitus	0.000246	0.000529	CcSEcCtD
Cladribine—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000246	0.000529	CcSEcCtD
Cladribine—Pain—Orlistat—type 2 diabetes mellitus	0.000245	0.000526	CcSEcCtD
Cladribine—Chest pain—Losartan—type 2 diabetes mellitus	0.000244	0.000525	CcSEcCtD
Cladribine—Arthralgia—Losartan—type 2 diabetes mellitus	0.000244	0.000525	CcSEcCtD
Cladribine—Myalgia—Losartan—type 2 diabetes mellitus	0.000244	0.000525	CcSEcCtD
Cladribine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000244	0.000525	CcSEcCtD
Cladribine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000244	0.000524	CcSEcCtD
Cladribine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000244	0.000524	CcSEcCtD
Cladribine—Anxiety—Losartan—type 2 diabetes mellitus	0.000243	0.000523	CcSEcCtD
Cladribine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000243	0.000522	CcSEcCtD
Cladribine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000242	0.00052	CcSEcCtD
Cladribine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000242	0.00052	CcSEcCtD
Cladribine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000242	0.000519	CcSEcCtD
Cladribine—Discomfort—Losartan—type 2 diabetes mellitus	0.000241	0.000519	CcSEcCtD
Cladribine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.00024	0.000517	CcSEcCtD
Cladribine—Headache—Bromocriptine—type 2 diabetes mellitus	0.00024	0.000517	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.00024	0.000516	CcSEcCtD
Cladribine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00024	0.000516	CcSEcCtD
Cladribine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000237	0.00051	CcSEcCtD
Cladribine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000237	0.000509	CcSEcCtD
Cladribine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000237	0.000509	CcSEcCtD
Cladribine—Confusional state—Losartan—type 2 diabetes mellitus	0.000236	0.000507	CcSEcCtD
Cladribine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000236	0.000507	CcSEcCtD
Cladribine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000235	0.000505	CcSEcCtD
Cladribine—Somnolence—Metformin—type 2 diabetes mellitus	0.000234	0.000504	CcSEcCtD
Cladribine—Oedema—Losartan—type 2 diabetes mellitus	0.000234	0.000503	CcSEcCtD
Cladribine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000234	0.000503	CcSEcCtD
Cladribine—Infection—Losartan—type 2 diabetes mellitus	0.000233	0.0005	CcSEcCtD
Cladribine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000232	0.0005	CcSEcCtD
Cladribine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000232	0.000499	CcSEcCtD
Cladribine—Urticaria—Valsartan—type 2 diabetes mellitus	0.00023	0.000494	CcSEcCtD
Cladribine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.00023	0.000494	CcSEcCtD
Cladribine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000229	0.000493	CcSEcCtD
Cladribine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000229	0.000493	CcSEcCtD
Cladribine—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000229	0.000492	CcSEcCtD
Cladribine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000228	0.000491	CcSEcCtD
Cladribine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000228	0.000491	CcSEcCtD
Cladribine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000228	0.00049	CcSEcCtD
Cladribine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000228	0.000489	CcSEcCtD
Cladribine—Fatigue—Metformin—type 2 diabetes mellitus	0.000227	0.000489	CcSEcCtD
Cladribine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000227	0.000488	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000227	0.000487	CcSEcCtD
Cladribine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000226	0.000487	CcSEcCtD
Cladribine—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000226	0.000486	CcSEcCtD
Cladribine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000226	0.000486	CcSEcCtD
Cladribine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000226	0.000486	CcSEcCtD
Cladribine—Constipation—Metformin—type 2 diabetes mellitus	0.000225	0.000485	CcSEcCtD
Cladribine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000223	0.00048	CcSEcCtD
Cladribine—Anorexia—Losartan—type 2 diabetes mellitus	0.000223	0.00048	CcSEcCtD
Cladribine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000223	0.00048	CcSEcCtD
Cladribine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000223	0.000479	CcSEcCtD
Cladribine—Malaise—Ramipril—type 2 diabetes mellitus	0.000222	0.000477	CcSEcCtD
Cladribine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000222	0.000477	CcSEcCtD
Cladribine—Rash—Glyburide—type 2 diabetes mellitus	0.000221	0.000476	CcSEcCtD
Cladribine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000221	0.000475	CcSEcCtD
Cladribine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000221	0.000475	CcSEcCtD
Cladribine—Headache—Glyburide—type 2 diabetes mellitus	0.00022	0.000473	CcSEcCtD
Cladribine—Hypotension—Losartan—type 2 diabetes mellitus	0.000219	0.00047	CcSEcCtD
Cladribine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000217	0.000467	CcSEcCtD
Cladribine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000216	0.000465	CcSEcCtD
Cladribine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000216	0.000463	CcSEcCtD
Cladribine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000216	0.000463	CcSEcCtD
Cladribine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000215	0.000462	CcSEcCtD
Cladribine—Cough—Ramipril—type 2 diabetes mellitus	0.000215	0.000461	CcSEcCtD
Cladribine—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000214	0.000461	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000213	0.000458	CcSEcCtD
Cladribine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000213	0.000458	CcSEcCtD
Cladribine—Constipation—Irbesartan—type 2 diabetes mellitus	0.000213	0.000457	CcSEcCtD
Cladribine—Pain—Irbesartan—type 2 diabetes mellitus	0.000213	0.000457	CcSEcCtD
Cladribine—Insomnia—Losartan—type 2 diabetes mellitus	0.000212	0.000455	CcSEcCtD
Cladribine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000211	0.000453	CcSEcCtD
Cladribine—Paraesthesia—Losartan—type 2 diabetes mellitus	0.00021	0.000452	CcSEcCtD
Cladribine—Urticaria—Metformin—type 2 diabetes mellitus	0.000209	0.00045	CcSEcCtD
Cladribine—Myalgia—Ramipril—type 2 diabetes mellitus	0.000209	0.00045	CcSEcCtD
Cladribine—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000209	0.00045	CcSEcCtD
Cladribine—Chest pain—Ramipril—type 2 diabetes mellitus	0.000209	0.00045	CcSEcCtD
Cladribine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000209	0.000449	CcSEcCtD
Cladribine—Anxiety—Ramipril—type 2 diabetes mellitus	0.000209	0.000449	CcSEcCtD
Cladribine—Nausea—Glyburide—type 2 diabetes mellitus	0.000208	0.000448	CcSEcCtD
Cladribine—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000208	0.000448	CcSEcCtD
Cladribine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000208	0.000448	CcSEcCtD
Cladribine—Somnolence—Losartan—type 2 diabetes mellitus	0.000208	0.000447	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000208	0.000447	CcSEcCtD
Cladribine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000208	0.000446	CcSEcCtD
Cladribine—Discomfort—Ramipril—type 2 diabetes mellitus	0.000207	0.000445	CcSEcCtD
Cladribine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000205	0.000441	CcSEcCtD
Cladribine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000205	0.000441	CcSEcCtD
Cladribine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000205	0.00044	CcSEcCtD
Cladribine—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000203	0.000437	CcSEcCtD
Cladribine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000203	0.000437	CcSEcCtD
Cladribine—Confusional state—Ramipril—type 2 diabetes mellitus	0.000202	0.000435	CcSEcCtD
Cladribine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000202	0.000435	CcSEcCtD
Cladribine—Fatigue—Losartan—type 2 diabetes mellitus	0.000202	0.000434	CcSEcCtD
Cladribine—Oedema—Ramipril—type 2 diabetes mellitus	0.000201	0.000432	CcSEcCtD
Cladribine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.0002	0.000431	CcSEcCtD
Cladribine—Constipation—Losartan—type 2 diabetes mellitus	0.0002	0.00043	CcSEcCtD
Cladribine—Pain—Losartan—type 2 diabetes mellitus	0.0002	0.00043	CcSEcCtD
Cladribine—Rash—Gliclazide—type 2 diabetes mellitus	0.000199	0.000427	CcSEcCtD
Cladribine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000198	0.000427	CcSEcCtD
Cladribine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000198	0.000426	CcSEcCtD
Cladribine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000198	0.000425	CcSEcCtD
Cladribine—Headache—Gliclazide—type 2 diabetes mellitus	0.000197	0.000424	CcSEcCtD
Cladribine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000197	0.000423	CcSEcCtD
Cladribine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000197	0.000423	CcSEcCtD
Cladribine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000197	0.000423	CcSEcCtD
Cladribine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000197	0.000422	CcSEcCtD
Cladribine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000196	0.000421	CcSEcCtD
Cladribine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000196	0.000421	CcSEcCtD
Cladribine—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000195	0.000419	CcSEcCtD
Cladribine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000194	0.000417	CcSEcCtD
Cladribine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000193	0.000415	CcSEcCtD
Cladribine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000191	0.000412	CcSEcCtD
Cladribine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000191	0.000411	CcSEcCtD
Cladribine—Anorexia—Ramipril—type 2 diabetes mellitus	0.000191	0.000411	CcSEcCtD
Cladribine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000189	0.000407	CcSEcCtD
Cladribine—Asthenia—Metformin—type 2 diabetes mellitus	0.000189	0.000407	CcSEcCtD
Cladribine—Hypotension—Ramipril—type 2 diabetes mellitus	0.000188	0.000403	CcSEcCtD
Cladribine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000187	0.000402	CcSEcCtD
Cladribine—Pruritus—Metformin—type 2 diabetes mellitus	0.000186	0.000401	CcSEcCtD
Cladribine—Urticaria—Losartan—type 2 diabetes mellitus	0.000186	0.0004	CcSEcCtD
Cladribine—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000185	0.000398	CcSEcCtD
Cladribine—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000185	0.000398	CcSEcCtD
Cladribine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000184	0.000396	CcSEcCtD
Cladribine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000183	0.000394	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000183	0.000393	CcSEcCtD
Cladribine—Rash—Valsartan—type 2 diabetes mellitus	0.000182	0.000392	CcSEcCtD
Cladribine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000182	0.000392	CcSEcCtD
Cladribine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000182	0.000391	CcSEcCtD
Cladribine—Insomnia—Ramipril—type 2 diabetes mellitus	0.000182	0.00039	CcSEcCtD
Cladribine—Headache—Valsartan—type 2 diabetes mellitus	0.000181	0.00039	CcSEcCtD
Cladribine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.00018	0.000388	CcSEcCtD
Cladribine—Rash—Orlistat—type 2 diabetes mellitus	0.00018	0.000388	CcSEcCtD
Cladribine—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.00018	0.000387	CcSEcCtD
Cladribine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00018	0.000387	CcSEcCtD
Cladribine—Headache—Orlistat—type 2 diabetes mellitus	0.000179	0.000385	CcSEcCtD
Cladribine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000179	0.000385	CcSEcCtD
Cladribine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000178	0.000384	CcSEcCtD
Cladribine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000178	0.000384	CcSEcCtD
Cladribine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000176	0.000378	CcSEcCtD
Cladribine—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000174	0.000375	CcSEcCtD
Cladribine—Dizziness—Metformin—type 2 diabetes mellitus	0.000174	0.000375	CcSEcCtD
Cladribine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000173	0.000373	CcSEcCtD
Cladribine—Fatigue—Ramipril—type 2 diabetes mellitus	0.000173	0.000372	CcSEcCtD
Cladribine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000172	0.000371	CcSEcCtD
Cladribine—Nausea—Valsartan—type 2 diabetes mellitus	0.000172	0.00037	CcSEcCtD
Cladribine—Constipation—Ramipril—type 2 diabetes mellitus	0.000172	0.000369	CcSEcCtD
Cladribine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.00017	0.000366	CcSEcCtD
Cladribine—Nausea—Orlistat—type 2 diabetes mellitus	0.00017	0.000365	CcSEcCtD
Cladribine—Asthenia—Losartan—type 2 diabetes mellitus	0.000168	0.000361	CcSEcCtD
Cladribine—Vomiting—Metformin—type 2 diabetes mellitus	0.000168	0.00036	CcSEcCtD
Cladribine—Rash—Metformin—type 2 diabetes mellitus	0.000166	0.000357	CcSEcCtD
Cladribine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000166	0.000357	CcSEcCtD
Cladribine—Pruritus—Losartan—type 2 diabetes mellitus	0.000166	0.000356	CcSEcCtD
Cladribine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000165	0.000356	CcSEcCtD
Cladribine—Headache—Metformin—type 2 diabetes mellitus	0.000165	0.000355	CcSEcCtD
Cladribine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000164	0.000354	CcSEcCtD
Cladribine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000164	0.000353	CcSEcCtD
Cladribine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.00016	0.000344	CcSEcCtD
Cladribine—Urticaria—Ramipril—type 2 diabetes mellitus	0.000159	0.000343	CcSEcCtD
Cladribine—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000159	0.000341	CcSEcCtD
Cladribine—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000159	0.000341	CcSEcCtD
Cladribine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000158	0.00034	CcSEcCtD
Cladribine—Rash—Irbesartan—type 2 diabetes mellitus	0.000157	0.000337	CcSEcCtD
Cladribine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000157	0.000337	CcSEcCtD
Cladribine—Nausea—Metformin—type 2 diabetes mellitus	0.000157	0.000337	CcSEcCtD
Cladribine—Headache—Irbesartan—type 2 diabetes mellitus	0.000156	0.000335	CcSEcCtD
Cladribine—Dizziness—Losartan—type 2 diabetes mellitus	0.000155	0.000333	CcSEcCtD
Cladribine—Vomiting—Losartan—type 2 diabetes mellitus	0.000149	0.00032	CcSEcCtD
Cladribine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000148	0.000318	CcSEcCtD
Cladribine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000148	0.000318	CcSEcCtD
Cladribine—Rash—Losartan—type 2 diabetes mellitus	0.000148	0.000317	CcSEcCtD
Cladribine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000147	0.000317	CcSEcCtD
Cladribine—Headache—Losartan—type 2 diabetes mellitus	0.000147	0.000315	CcSEcCtD
Cladribine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000144	0.00031	CcSEcCtD
Cladribine—Pruritus—Ramipril—type 2 diabetes mellitus	0.000142	0.000305	CcSEcCtD
Cladribine—Nausea—Losartan—type 2 diabetes mellitus	0.000139	0.000299	CcSEcCtD
Cladribine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000137	0.000295	CcSEcCtD
Cladribine—Dizziness—Ramipril—type 2 diabetes mellitus	0.000133	0.000285	CcSEcCtD
Cladribine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000128	0.000274	CcSEcCtD
Cladribine—Rash—Ramipril—type 2 diabetes mellitus	0.000127	0.000272	CcSEcCtD
Cladribine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000126	0.000272	CcSEcCtD
Cladribine—Headache—Ramipril—type 2 diabetes mellitus	0.000126	0.00027	CcSEcCtD
Cladribine—Nausea—Ramipril—type 2 diabetes mellitus	0.000119	0.000256	CcSEcCtD
Cladribine—SLC22A1—Metabolism—ACACA—type 2 diabetes mellitus	3.71e-05	0.000138	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—HSD17B3—type 2 diabetes mellitus	3.71e-05	0.000138	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—STAR—type 2 diabetes mellitus	3.71e-05	0.000138	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	3.71e-05	0.000138	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.71e-05	0.000138	CbGpPWpGaD
Cladribine—DCK—Metabolism—LPL—type 2 diabetes mellitus	3.69e-05	0.000138	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—COX2—type 2 diabetes mellitus	3.67e-05	0.000137	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SLC5A2—type 2 diabetes mellitus	3.67e-05	0.000137	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—NCOA6—type 2 diabetes mellitus	3.65e-05	0.000136	CbGpPWpGaD
Cladribine—DCK—Metabolism—ADCY5—type 2 diabetes mellitus	3.62e-05	0.000135	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—NCOA6—type 2 diabetes mellitus	3.61e-05	0.000135	CbGpPWpGaD
Cladribine—DCK—Metabolism—GPX1—type 2 diabetes mellitus	3.6e-05	0.000134	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—HSD11B1—type 2 diabetes mellitus	3.59e-05	0.000134	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—UCP3—type 2 diabetes mellitus	3.59e-05	0.000134	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—UCP2—type 2 diabetes mellitus	3.59e-05	0.000134	CbGpPWpGaD
Cladribine—RRM2—Metabolism—MTHFR—type 2 diabetes mellitus	3.56e-05	0.000133	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ABCC8—type 2 diabetes mellitus	3.56e-05	0.000133	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CBS—type 2 diabetes mellitus	3.56e-05	0.000133	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—UCP2—type 2 diabetes mellitus	3.55e-05	0.000132	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—HSD11B1—type 2 diabetes mellitus	3.55e-05	0.000132	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—UCP3—type 2 diabetes mellitus	3.55e-05	0.000132	CbGpPWpGaD
Cladribine—DCK—Metabolism—CD36—type 2 diabetes mellitus	3.51e-05	0.000131	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PPARG—type 2 diabetes mellitus	3.5e-05	0.000131	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PPARA—type 2 diabetes mellitus	3.49e-05	0.00013	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.47e-05	0.000129	CbGpPWpGaD
Cladribine—DCK—Metabolism—PPP2CA—type 2 diabetes mellitus	3.47e-05	0.000129	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.45e-05	0.000129	CbGpPWpGaD
Cladribine—RRM1—Metabolism—INS—type 2 diabetes mellitus	3.44e-05	0.000128	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.43e-05	0.000128	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—COX2—type 2 diabetes mellitus	3.42e-05	0.000128	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SLC5A2—type 2 diabetes mellitus	3.42e-05	0.000128	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.42e-05	0.000127	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.41e-05	0.000127	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.38e-05	0.000126	CbGpPWpGaD
Cladribine—RRM2—Metabolism—AGT—type 2 diabetes mellitus	3.38e-05	0.000126	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PCK1—type 2 diabetes mellitus	3.37e-05	0.000126	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—NCOA6—type 2 diabetes mellitus	3.36e-05	0.000125	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PCK1—type 2 diabetes mellitus	3.34e-05	0.000124	CbGpPWpGaD
Cladribine—DCK—Metabolism—MTHFR—type 2 diabetes mellitus	3.33e-05	0.000124	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CALM1—type 2 diabetes mellitus	3.32e-05	0.000124	CbGpPWpGaD
Cladribine—RRM2—Metabolism—APOE—type 2 diabetes mellitus	3.31e-05	0.000124	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—UCP2—type 2 diabetes mellitus	3.31e-05	0.000123	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—UCP3—type 2 diabetes mellitus	3.31e-05	0.000123	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—HSD11B1—type 2 diabetes mellitus	3.31e-05	0.000123	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.31e-05	0.000123	CbGpPWpGaD
Cladribine—RRM2—Metabolism—APOA1—type 2 diabetes mellitus	3.28e-05	0.000122	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.27e-05	0.000122	CbGpPWpGaD
Cladribine—DCK—Metabolism—PPARA—type 2 diabetes mellitus	3.26e-05	0.000122	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.2e-05	0.000119	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.18e-05	0.000119	CbGpPWpGaD
Cladribine—DCK—Metabolism—AGT—type 2 diabetes mellitus	3.16e-05	0.000118	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—HK1—type 2 diabetes mellitus	3.16e-05	0.000118	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.15e-05	0.000118	CbGpPWpGaD
Cladribine—RRM1—Metabolism—ALB—type 2 diabetes mellitus	3.15e-05	0.000117	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—HK1—type 2 diabetes mellitus	3.12e-05	0.000116	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PCK1—type 2 diabetes mellitus	3.11e-05	0.000116	CbGpPWpGaD
Cladribine—DCK—Metabolism—CALM1—type 2 diabetes mellitus	3.11e-05	0.000116	CbGpPWpGaD
Cladribine—DCK—Metabolism—APOE—type 2 diabetes mellitus	3.1e-05	0.000115	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.09e-05	0.000115	CbGpPWpGaD
Cladribine—DCK—Metabolism—APOA1—type 2 diabetes mellitus	3.06e-05	0.000114	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.06e-05	0.000114	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—LPA—type 2 diabetes mellitus	3.05e-05	0.000114	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—HSD3B2—type 2 diabetes mellitus	3.05e-05	0.000114	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—KCNJ11—type 2 diabetes mellitus	3.05e-05	0.000114	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GCKR—type 2 diabetes mellitus	3.05e-05	0.000114	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.05e-05	0.000114	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—LPA—type 2 diabetes mellitus	3.02e-05	0.000113	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—HSD3B2—type 2 diabetes mellitus	3.02e-05	0.000113	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—KCNJ11—type 2 diabetes mellitus	3.02e-05	0.000113	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GCKR—type 2 diabetes mellitus	3.02e-05	0.000113	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.01e-05	0.000112	CbGpPWpGaD
Cladribine—RRM1—Metabolism—NOS3—type 2 diabetes mellitus	3.01e-05	0.000112	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ALDOB—type 2 diabetes mellitus	2.92e-05	0.000109	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—HK1—type 2 diabetes mellitus	2.91e-05	0.000109	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ALDOB—type 2 diabetes mellitus	2.89e-05	0.000108	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PPARG—type 2 diabetes mellitus	2.89e-05	0.000108	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.85e-05	0.000106	CbGpPWpGaD
Cladribine—RRM2—Metabolism—INS—type 2 diabetes mellitus	2.83e-05	0.000106	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—LPA—type 2 diabetes mellitus	2.81e-05	0.000105	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—KCNJ11—type 2 diabetes mellitus	2.81e-05	0.000105	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—HSD3B2—type 2 diabetes mellitus	2.81e-05	0.000105	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GCKR—type 2 diabetes mellitus	2.81e-05	0.000105	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.79e-05	0.000104	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—AKT1—type 2 diabetes mellitus	2.78e-05	0.000104	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.76e-05	0.000103	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PTGS2—type 2 diabetes mellitus	2.76e-05	0.000103	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GLP1R—type 2 diabetes mellitus	2.72e-05	0.000101	CbGpPWpGaD
Cladribine—DCK—Metabolism—PPARG—type 2 diabetes mellitus	2.7e-05	0.000101	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ALDOB—type 2 diabetes mellitus	2.7e-05	0.000101	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GLP1R—type 2 diabetes mellitus	2.69e-05	0.0001	CbGpPWpGaD
Cladribine—DCK—Metabolism—INS—type 2 diabetes mellitus	2.64e-05	9.86e-05	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.62e-05	9.75e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—ALB—type 2 diabetes mellitus	2.59e-05	9.67e-05	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.59e-05	9.65e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.57e-05	9.59e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SLC2A2—type 2 diabetes mellitus	2.54e-05	9.46e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SLC2A2—type 2 diabetes mellitus	2.51e-05	9.36e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GLP1R—type 2 diabetes mellitus	2.51e-05	9.35e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CPT1A—type 2 diabetes mellitus	2.49e-05	9.27e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—MTR—type 2 diabetes mellitus	2.49e-05	9.27e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.48e-05	9.25e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—NOS3—type 2 diabetes mellitus	2.48e-05	9.25e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CPT1A—type 2 diabetes mellitus	2.46e-05	9.17e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—MTR—type 2 diabetes mellitus	2.46e-05	9.17e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—NAMPT—type 2 diabetes mellitus	2.44e-05	9.09e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—ALB—type 2 diabetes mellitus	2.42e-05	9.04e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—LIPC—type 2 diabetes mellitus	2.42e-05	9.03e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—HBA1—type 2 diabetes mellitus	2.42e-05	9.03e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GCK—type 2 diabetes mellitus	2.42e-05	9.03e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—NAMPT—type 2 diabetes mellitus	2.41e-05	8.99e-05	CbGpPWpGaD
Cladribine—PNP—Metabolism—AKT1—type 2 diabetes mellitus	2.41e-05	8.99e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.41e-05	8.99e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP11A1—type 2 diabetes mellitus	2.41e-05	8.98e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—HBA1—type 2 diabetes mellitus	2.4e-05	8.94e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—LIPC—type 2 diabetes mellitus	2.4e-05	8.94e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GCK—type 2 diabetes mellitus	2.4e-05	8.94e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP11A1—type 2 diabetes mellitus	2.38e-05	8.88e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SLC9A1—type 2 diabetes mellitus	2.36e-05	8.81e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SLC2A2—type 2 diabetes mellitus	2.34e-05	8.73e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SLC9A1—type 2 diabetes mellitus	2.34e-05	8.72e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CETP—type 2 diabetes mellitus	2.34e-05	8.71e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PIK3R1—type 2 diabetes mellitus	2.32e-05	8.65e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—NOS3—type 2 diabetes mellitus	2.32e-05	8.65e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CETP—type 2 diabetes mellitus	2.31e-05	8.62e-05	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—AKT1—type 2 diabetes mellitus	2.31e-05	8.6e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—MTR—type 2 diabetes mellitus	2.29e-05	8.55e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CPT1A—type 2 diabetes mellitus	2.29e-05	8.55e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PTGS2—type 2 diabetes mellitus	2.27e-05	8.46e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—NAMPT—type 2 diabetes mellitus	2.25e-05	8.38e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—HBA1—type 2 diabetes mellitus	2.23e-05	8.33e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—LIPC—type 2 diabetes mellitus	2.23e-05	8.33e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GCK—type 2 diabetes mellitus	2.23e-05	8.33e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP11A1—type 2 diabetes mellitus	2.22e-05	8.28e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SLC9A1—type 2 diabetes mellitus	2.18e-05	8.13e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SNAP25—type 2 diabetes mellitus	2.17e-05	8.1e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SREBF1—type 2 diabetes mellitus	2.17e-05	8.1e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PSMD6—type 2 diabetes mellitus	2.17e-05	8.1e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CETP—type 2 diabetes mellitus	2.16e-05	8.04e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SREBF1—type 2 diabetes mellitus	2.15e-05	8.02e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SNAP25—type 2 diabetes mellitus	2.15e-05	8.02e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PSMD6—type 2 diabetes mellitus	2.15e-05	8.02e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CTGF—type 2 diabetes mellitus	2.13e-05	7.95e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—PTGS2—type 2 diabetes mellitus	2.12e-05	7.91e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—HMGCR—type 2 diabetes mellitus	2.11e-05	7.88e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CTGF—type 2 diabetes mellitus	2.11e-05	7.87e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—HMGCR—type 2 diabetes mellitus	2.09e-05	7.8e-05	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.07e-05	7.72e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ADRA2A—type 2 diabetes mellitus	2.07e-05	7.71e-05	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.05e-05	7.64e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ADRA2A—type 2 diabetes mellitus	2.05e-05	7.63e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SREBF1—type 2 diabetes mellitus	2e-05	7.47e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PSMD6—type 2 diabetes mellitus	2e-05	7.47e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SNAP25—type 2 diabetes mellitus	2e-05	7.47e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP2E1—type 2 diabetes mellitus	1.99e-05	7.41e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CTGF—type 2 diabetes mellitus	1.97e-05	7.33e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP2E1—type 2 diabetes mellitus	1.97e-05	7.33e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SLC2A1—type 2 diabetes mellitus	1.96e-05	7.33e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP1A2—type 2 diabetes mellitus	1.96e-05	7.33e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—HMGCR—type 2 diabetes mellitus	1.95e-05	7.27e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SLC2A1—type 2 diabetes mellitus	1.94e-05	7.25e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP1A2—type 2 diabetes mellitus	1.94e-05	7.25e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP3A4—type 2 diabetes mellitus	1.92e-05	7.14e-05	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.91e-05	7.13e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ADRA2A—type 2 diabetes mellitus	1.91e-05	7.11e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP3A4—type 2 diabetes mellitus	1.9e-05	7.07e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GCG—type 2 diabetes mellitus	1.88e-05	7.02e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SLC2A4—type 2 diabetes mellitus	1.88e-05	7.02e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GCG—type 2 diabetes mellitus	1.86e-05	6.95e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SLC2A4—type 2 diabetes mellitus	1.86e-05	6.95e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.83e-05	6.83e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.81e-05	6.76e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.81e-05	6.76e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.77e-05	6.59e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GCG—type 2 diabetes mellitus	1.74e-05	6.48e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.74e-05	6.48e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.62e-05	6.05e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GNB3—type 2 diabetes mellitus	1.62e-05	6.05e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—HMOX1—type 2 diabetes mellitus	1.62e-05	6.03e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GNB3—type 2 diabetes mellitus	1.61e-05	5.99e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.61e-05	5.99e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—HMOX1—type 2 diabetes mellitus	1.6e-05	5.96e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CAT—type 2 diabetes mellitus	1.59e-05	5.95e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CAT—type 2 diabetes mellitus	1.58e-05	5.88e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—APOB—type 2 diabetes mellitus	1.55e-05	5.77e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—APOB—type 2 diabetes mellitus	1.53e-05	5.71e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GSTM1—type 2 diabetes mellitus	1.51e-05	5.61e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.5e-05	5.58e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GNB3—type 2 diabetes mellitus	1.5e-05	5.58e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—HMOX1—type 2 diabetes mellitus	1.49e-05	5.56e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.49e-05	5.56e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—LPL—type 2 diabetes mellitus	1.48e-05	5.51e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CAT—type 2 diabetes mellitus	1.47e-05	5.48e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—LPL—type 2 diabetes mellitus	1.46e-05	5.45e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ADCY5—type 2 diabetes mellitus	1.45e-05	5.4e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—GPX1—type 2 diabetes mellitus	1.44e-05	5.38e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.43e-05	5.34e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—APOB—type 2 diabetes mellitus	1.43e-05	5.32e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—GPX1—type 2 diabetes mellitus	1.43e-05	5.32e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CD36—type 2 diabetes mellitus	1.4e-05	5.24e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CD36—type 2 diabetes mellitus	1.39e-05	5.18e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GSTM1—type 2 diabetes mellitus	1.39e-05	5.18e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.39e-05	5.17e-05	CbGpPWpGaD
Cladribine—RRM1—Metabolism—AKT1—type 2 diabetes mellitus	1.39e-05	5.17e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.37e-05	5.12e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—LPL—type 2 diabetes mellitus	1.36e-05	5.08e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ADCY5—type 2 diabetes mellitus	1.33e-05	4.98e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—MTHFR—type 2 diabetes mellitus	1.33e-05	4.96e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—GPX1—type 2 diabetes mellitus	1.33e-05	4.96e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.32e-05	4.91e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PPARA—type 2 diabetes mellitus	1.31e-05	4.87e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CD36—type 2 diabetes mellitus	1.3e-05	4.83e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PPARA—type 2 diabetes mellitus	1.29e-05	4.82e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.28e-05	4.77e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—AGT—type 2 diabetes mellitus	1.26e-05	4.71e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—AGT—type 2 diabetes mellitus	1.25e-05	4.67e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CALM1—type 2 diabetes mellitus	1.24e-05	4.64e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—APOE—type 2 diabetes mellitus	1.24e-05	4.62e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CALM1—type 2 diabetes mellitus	1.23e-05	4.59e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—MTHFR—type 2 diabetes mellitus	1.23e-05	4.58e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—APOE—type 2 diabetes mellitus	1.23e-05	4.57e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—APOA1—type 2 diabetes mellitus	1.22e-05	4.57e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—APOA1—type 2 diabetes mellitus	1.21e-05	4.52e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PPARA—type 2 diabetes mellitus	1.2e-05	4.49e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—AGT—type 2 diabetes mellitus	1.17e-05	4.35e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CALM1—type 2 diabetes mellitus	1.15e-05	4.28e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—APOE—type 2 diabetes mellitus	1.14e-05	4.26e-05	CbGpPWpGaD
Cladribine—RRM2—Metabolism—AKT1—type 2 diabetes mellitus	1.14e-05	4.25e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—APOA1—type 2 diabetes mellitus	1.13e-05	4.21e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PPARG—type 2 diabetes mellitus	1.08e-05	4.02e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PPARG—type 2 diabetes mellitus	1.07e-05	3.98e-05	CbGpPWpGaD
Cladribine—DCK—Metabolism—AKT1—type 2 diabetes mellitus	1.07e-05	3.98e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—INS—type 2 diabetes mellitus	1.06e-05	3.95e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—INS—type 2 diabetes mellitus	1.05e-05	3.91e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PPARG—type 2 diabetes mellitus	9.95e-06	3.71e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—INS—type 2 diabetes mellitus	9.76e-06	3.64e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ALB—type 2 diabetes mellitus	9.7e-06	3.62e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ALB—type 2 diabetes mellitus	9.6e-06	3.58e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PIK3R1—type 2 diabetes mellitus	9.28e-06	3.46e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—NOS3—type 2 diabetes mellitus	9.28e-06	3.46e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PIK3R1—type 2 diabetes mellitus	9.19e-06	3.43e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—NOS3—type 2 diabetes mellitus	9.19e-06	3.43e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ALB—type 2 diabetes mellitus	8.95e-06	3.34e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—NOS3—type 2 diabetes mellitus	8.56e-06	3.19e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PIK3R1—type 2 diabetes mellitus	8.56e-06	3.19e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PTGS2—type 2 diabetes mellitus	8.49e-06	3.17e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PTGS2—type 2 diabetes mellitus	8.4e-06	3.13e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PTGS2—type 2 diabetes mellitus	7.83e-06	2.92e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—AKT1—type 2 diabetes mellitus	4.27e-06	1.59e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—AKT1—type 2 diabetes mellitus	4.22e-06	1.57e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—AKT1—type 2 diabetes mellitus	3.94e-06	1.47e-05	CbGpPWpGaD
